IVF leader claims natural conception is for people with ‘genetic advantages’
CEO Stirs Debate on IVF and Natural Conception Noor Siddiqui, the CEO of an in vitro fertilization (IVF) company called Orchid, has stirred some controversy with his recent comments. He remarked that while sexual activity is often viewed as a form of enjoyment, IVF is focused on the serious business of creating life. Siddiqui’s company […]
Shaun King Shares False Information About ‘Starving’ Palestinian Child with Genetic Condition Who Received Assistance from Israel
Controversy Surrounds Claims of Starvation in Gaza Sean King, a prominent radical left activist, shared photos on Wednesday of a Palestinian child in Gaza, claiming the child was “starved.” However, it turns out the child was dealing with a genetic condition and had received medical treatment in Israel. King’s article on his website states that […]
Images of a starving boy in Gaza don’t reveal the complete picture, as critics point out he has genetic disorders.
Some critics point out that while the issue of starvation in Gaza is serious, there are concerns regarding the portrayal of certain children suffering there. A particular child, identified as Mohammed Zakhalia Ayub al Matowuk, has been highlighted in various news outlets, including The New York Times and BBC. However, a pro-Israel organization noted something […]
New IVF method incorporates DNA from three individuals to avoid genetic disorders
Breakthrough in Genetic Disease Treatment for UK Children Scientists from Newcastle University announced on Wednesday that eight children in the UK have successfully overcome severe genetic diseases. This groundbreaking technique, currently banned in the US, involves transferring genetic material from a mother’s fertilized egg, along with the father’s sperm nucleus, to healthy eggs from an […]
States initiate legal measures as 23andMe tries to sell customer genetic data during bankruptcy
23andMe Faces Lawsuit Over Genetic Data Sales Amid Bankruptcy This week, 27 states along with the District of Columbia filed a lawsuit against 23andMe in the U.S. Bankruptcy Court in the Eastern District of Missouri. The main contention is that the genetic testing company lacks the right to sell its clients’ genetic information to whoever […]
States contest 23andMe’s ability to sell genetic data amid bankruptcy
23andMe Faces Legal Challenges Amid Bankruptcy 23andMe is currently embroiled in a lawsuit over its intentions to sell customers’ genetic data, which has raised significant concerns about privacy. This week, 27 states, along with the District of Columbia, took legal action against the company in the U.S. Bankruptcy Court located in the Eastern District of […]
Couples using IVF are investing heavily in genetic screening for embryos
Perhaps it’s something she’s just born with, or maybe it’s more about genetic optimization? With a new $5,999 service unveiled by a US biotechnology firm, prospective parents using in vitro fertilization (IVF) will soon have the ability to select embryos based on their potential disease risks, including conditions that could develop later in life. “Before […]
‘Selfish’ Genes Called “Introners” Found to Be a Key Factor in Genetic Complexity: Study
New Research on Genetic Elements Recent studies have unveiled that genetic elements referred to as “introners” play a significant role in the spread of introns both within species and among different species. This research presents evidence for eight instances where introners migrated between unrelated species, marking the first confirmed example of this process known as […]
Pharmaceutical Company Purchases Failed DNA Collection Firm, Gaining Entry To World’s Largest Genetic Database
Regeneron to Acquire 23andMe for $256 Million Regeneron Pharmaceuticals, a U.S. biotechnology firm, has announced its acquisition of genetic testing company 23andMe following a winning bid of $256 million during a bankruptcy auction. This move comes as part of a broader strategy to enhance access to genetic data. The acquisition allows Regeneron to obtain a […]
Regeneron Pharmaceuticals is set to purchase 23andMe and its genetic information for $256 million.
Regeneron Pharmaceuticals to Acquire 23andMe from Bankruptcy Regeneron Pharmaceuticals announced on Monday its intention to purchase 23andMe for $256 million as the company emerges from bankruptcy. This acquisition includes 23andMe’s personal genomic service, Total Health and Research Services, along with a substantial biobank that holds genetic data from over 15 million customers. All genetic testing […]